Mechanism of Action of Diazoxide

Introduction

Diazoxide is a benzothiadiazine derivative pharmacologically related to thiazide diuretics but lacking diuretic activity. It is primarily used as a hyperglycemic agent in the management of hypoglycemia due to hyperinsulinism and as a rapid-acting vasodilator in hypertensive emergencies (historical and limited current use). Diazoxide is a high-yield drug in pharmacology, endocrinology, and internal medicine examinations because of its ATP-sensitive potassium (KATP) channel–opening mechanism.

Mechanism of Action (Step-wise)

Diazoxide exerts its effects by opening ATP-sensitive potassium channels in pancreatic beta cells and vascular smooth muscle.

Step-wise mechanism:

ATP-Sensitive Potassium (KATP) Channels
KATP channels regulate membrane potential in pancreatic beta cells and vascular smooth muscle cells.

Opening of KATP Channels
Diazoxide binds to and opens KATP channels on the cell membrane.

Membrane Hyperpolarization
Opening of KATP channels allows potassium efflux, leading to membrane hyperpolarization.

Inhibition of Voltage-Gated Calcium Channels
Hyperpolarization prevents opening of voltage-gated calcium channels.

Reduced Intracellular Calcium Levels
Decreased calcium influx lowers intracellular calcium concentration.

Inhibition of Insulin Release (Pancreatic Effect)
In pancreatic beta cells, reduced calcium suppresses exocytosis of insulin-containing granules.

Vasodilation (Vascular Effect)
In vascular smooth muscle, reduced calcium causes relaxation and vasodilation.

Physiological Outcome

Increased blood glucose levels

Decreased peripheral vascular resistance

Pharmacokinetics

Absorption: Well absorbed orally

Distribution: Widely distributed; high protein binding

Metabolism: Minimal hepatic metabolism

Elimination: Renal excretion (largely unchanged)

Half-life: Approximately 24–36 hours

Special note: Causes sodium and water retention

Clinical Uses

Diazoxide is used in conditions characterized by excessive insulin secretion or acute hypertension:

Hyperinsulinemic hypoglycemia (congenital or acquired)

Insulinoma (medical management)

Persistent neonatal hypoglycemia

Hypertensive emergencies (rare/older use)

It is the drug of choice for suppressing insulin release in non-surgical hyperinsulinism.

Adverse Effects

Adverse effects are related to its metabolic and hemodynamic actions:

Metabolic:

Hyperglycemia

Hyperuricemia

Cardiovascular:

Hypotension

Reflex tachycardia

Fluid retention:

Edema

Heart failure exacerbation

Others:

Hypertrichosis (especially in children)

Nausea

Concomitant use of diuretics is often required to manage fluid retention.

Comparative Analysis (must include a table + explanation)
Comparison of Drugs Affecting Insulin Secretion
Feature Diazoxide Sulfonylureas Octreotide
Effect on KATP channel Opens Closes Indirect inhibition
Effect on insulin Decreases Increases Decreases
Route Oral Oral Parenteral
Use in hypoglycemia Yes No Yes
Hyperglycemia risk High Low Moderate

Explanation:
Diazoxide uniquely suppresses insulin release by opening KATP channels, the opposite action of sulfonylureas. Octreotide reduces insulin secretion via somatostatin receptor activation but is parenteral, whereas diazoxide allows oral management of chronic hyperinsulinism.

MCQs (10–15)

Diazoxide primarily acts by:
a) Blocking calcium channels
b) Opening potassium channels
c) Inhibiting insulin receptors
d) Stimulating glucagon release

Answer: b) Opening potassium channels

Diazoxide opens which specific channel?
a) Voltage-gated K⁺ channel
b) Calcium-activated K⁺ channel
c) ATP-sensitive K⁺ channel
d) Sodium channel

Answer: c) ATP-sensitive K⁺ channel

Diazoxide decreases insulin secretion by reducing:
a) Sodium influx
b) Potassium efflux
c) Calcium influx
d) Glucose uptake

Answer: c) Calcium influx

Diazoxide causes membrane hyperpolarization by:
a) Sodium influx
b) Potassium efflux
c) Calcium influx
d) Chloride efflux

Answer: b) Potassium efflux

Diazoxide is primarily used to treat:
a) Type 1 diabetes mellitus
b) Hyperinsulinemic hypoglycemia
c) Hypothyroidism
d) Hyperaldosteronism

Answer: b) Hyperinsulinemic hypoglycemia

Diazoxide has which effect on blood glucose?
a) Hypoglycemia
b) No effect
c) Hyperglycemia
d) Biphasic

Answer: c) Hyperglycemia

A characteristic adverse effect of diazoxide is:
a) Hypokalemia
b) Hypertrichosis
c) Bradycardia
d) Hypocalcemia

Answer: b) Hypertrichosis

Diazoxide relaxes vascular smooth muscle by:
a) Increasing intracellular calcium
b) Blocking alpha receptors
c) Reducing intracellular calcium
d) Inhibiting nitric oxide

Answer: c) Reducing intracellular calcium

Which drug has the opposite effect on KATP channels compared to diazoxide?
a) Insulin
b) Metformin
c) Sulfonylureas
d) Acarbose

Answer: c) Sulfonylureas

Diazoxide is structurally related to:
a) Loop diuretics
b) Thiazide diuretics
c) Potassium-sparing diuretics
d) Osmotic diuretics

Answer: b) Thiazide diuretics

FAQs (minimum 5)

What is the primary mechanism of diazoxide?
Opening of ATP-sensitive potassium channels leading to reduced insulin release.

Why does diazoxide cause hyperglycemia?
Because it suppresses insulin secretion from pancreatic beta cells.

Is diazoxide a diuretic?
No, despite being related to thiazides, it lacks diuretic activity.

Why does diazoxide cause hypertrichosis?
Due to stimulation of hair follicles, especially with chronic use.

Can diazoxide cause fluid retention?
Yes, sodium and water retention are common adverse effects.

Is diazoxide still used for hypertension?
Rarely; safer alternatives are now preferred.

References

Goodman & Gilman’s The Pharmacological Basis of Therapeutics
https://accessmedicine.mhmedical.com

Katzung BG. Basic and Clinical Pharmacology
https://accessmedicine.mhmedical.com

Tripathi KD. Essentials of Medical Pharmacology
https://www.jaypeebrothers.com

Harrison’s Principles of Internal Medicine
https://accessmedicine.mhmedical.com

Download